In the main Phase III trial, people lost about 15% of their visceral fat over 26 weeks on 2 mg a day
Unknown interactions increase risk exposure
The evaluable completers in this study therefore likely represent the intended treatment population, e.g
The dorsal putamen was selected as the center of the volume of interest due to its relatively homogenous mix of neurons and astrocytes, and suitable distance from bone and other regions that could compromise signal quality
Beyond that, using the thinnest needle that works for your situation, injecting slowly, and never forcing medication into tissue that feels resistant all protect long-term tissue health
February 5, 2025 Update: Eli Lilly and Novo Nordisk have requested Judge Marston to dismiss most of the claims in the master complaint, except for the Failure to Warn allegations